Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

10,710 total articles

Director Suliman Shehnaaz Sells Shares of Ultragenyx; Company Reports Q1 Misses Amid Executive Activity

Director Suliman Shehnaaz Sells Shares of Ultragenyx; Company Reports Q1 Misses Amid Executive Activity

A recent SEC filing disclosed that Suliman Shehnaaz, a director at Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), sold shares of the company's common stock. This transaction occurred in the context of other reported equity grants to Shehnaaz and mixed financial results for the first quarter of 2026.The sale involved $144,188 worth of shares on May 1…

Alphabet Entities Sell Ethos Technologies Stock Amid Market Dip; Earnings Data Provides Context

Alphabet Entities Sell Ethos Technologies Stock Amid Market Dip; Earnings Data Provides Context

Alphabet Inc. and its related corporate units executed multiple sales of Ethos Technologies Inc. (NASDAQ:LIFE) Class A Common Stock over May 14 and May 15, 2026. These transactions accounted for a total sale value of approximately $3.46 million across 147,552 shares, with weighted average selling prices ranging from $23.0093 to $24.2679 per share.T…

Oruka Therapeutics Insider Activity Details Sales and Option Exercises Amid Positive Clinical Data and Capital Raises

Oruka Therapeutics Insider Activity Details Sales and Option Exercises Amid Positive Clinical Data and Capital Raises

Senior Vice President of Finance Arjun Agarwal executed significant stock transactions for Oruka Therapeutics on May 18, 2026. These included the sale of common stock totaling $607,806 through a pre-planned trading strategy, alongside the acquisition of shares via employee stock option exercises. The activity occurs against a backdrop of positive c…

PennyMac CFO Sells Shares Under Established Trading Plan Amid Earnings Miss and Valuation Scrutiny

PennyMac CFO Sells Shares Under Established Trading Plan Amid Earnings Miss and Valuation Scrutiny

Daniel Perotti, Chief Financial Officer of PennyMac Financial Services, Inc., recently sold a portion of his company's common stock. This transaction occurred against a backdrop of recent financial underperformance for the firm, as reported in its first-quarter 2026 earnings and subsequent market movements. Stakeholders are closely analyzing these …

Insider Activity and Recent Earnings Report for Ambiq Micro Inc.

Insider Activity and Recent Earnings Report for Ambiq Micro Inc.

Ambiq Micro's CFO, Jeffrey Winzeler, recently executed transactions involving the sale of common stock after exercising options. This activity occurred while the company's stock is trading near recent highs. Separately, Ambiq Micro reported Q1 2026 earnings that surpassed analyst expectations, showing a significant year-over-year increase in revenu…